For those paying attention there are no surprises in this MedPage Today article. This quote sort of sums it all up for our patient community:
"The two key takeaways from this study are that drug prices are rising faster in the U.S. than in Europe, and that regardless of geography, drug prices do not reflect clinical benefit," Syed Yousuf Zafar, MD, of the Margolis Center for Health Policy at Duke University in Durham, North Carolina, told MedPage Today. (emphasis added)
No reason to think any of this will change anytime soon. Big Pharma owns the regulatory agencies and politicians. Status quo as far as the eye can see.
Best government money can buy and the most expensive HC in the world. Perfect combo for maximizing the profits for the people we rely on for our health care.
Stay Informed, Be Safe & Stay Well,
Ciao - K9
Written by
cujoe
To view profiles and participate in discussions please or .
Say it ain't so... the government and Big Pharma in bed together and the cancer patient is screwed... My word !!!
As I always say, take a look at the prices of generics in India and compare to US prices. Why is Lupron, a drug that has been around for so long, so expensive ???
OpenSecrets.org listings show both parties are willing recipients of monies from HC special interests. More influential politicians who populate the most powerful committees are at the top of the lists. No surprise there, altho' the presence of Sanders at the top and Warren not far behind probably indicates that the winners get rewarded for winning. I remember when a newly elected Senator from my state's first out of state trip was to attend a corporate-sponsored Health Care weekend event in Florida several weeks after being sworn into office. No doubt, an action intended to garner contributions for the next election cycle. Best to watch what politician actually do and not what they say they will do.
Term limits (maybe age, too) and 100% public financing of all elections would change the face of the US political landscape overnight. A legitimate third party that challenged the 2-party status quo might also break the choke hold of the current system.
Unfortunately (for us proles), too many powerful people and special interests benefit by the current system, so I would suggest you not hold your breath while you wait.
It seems from your history interacting at other HU forums (BTW, Why are you even here at FPC?), that most nearly all of your inputs strive to create controversy and continuous debate about issues that have nothing to do with the welfare of cancer patients.
As stated earlier, it seems your method of "discourse" is much better suited to what takes place on the aforementioned social media platforms.
No need to respond, as my replies to you are now and forever finished.
I know well how to private message and use it regularly to stay in touch with a very limited number of HU members. Most of my efforts at HU are geared toward posting information I consider worthy of consideration by those who read here.
10 July Update to the Biogen Alzheimer drug approval.
It seems the tight relationship between FDA staff and Biogen might just have gotten a bit TOO tight. Probably the first time in the history of the FDA that anything like that has ever happened?
FDA calls for federal investigation into its controversial Alzheimer’s drug approval - STAT News - July 9, 2021
Saw it earlier...despite recommendations from staff not to approve... we'll see how it pans out... Big money for approval of a new Alzheimer's drug... people are desperate for help...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
